XML 20 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Changes in Shareholders' Equity - USD ($)
Total
Number of common shares [Member]
Share capital [Member]
Contributed surplus [Member]
Accumulated deficit [Member]
Accumulated other comprehensive income (loss) [Member]
Beginning Balance, Shares at Oct. 31, 2017 1,586,038          
Beginning Balance at Oct. 31, 2017 $ 32,963   $ 442,814   $ (243,328) $ (166,523)
Share-based compensation $ 26,523     $ 26,523    
Shares issued for cash, Shares 188,604          
Shares issued for cash $ 2,645,136   2,645,136      
Share issue costs (118,759)   (118,759)      
Comprehensive income (loss) $ (783,050)       (908,869) 125,819
Ending Balance, Shares at Oct. 31, 2018 1,774,642          
Ending Balance at Oct. 31, 2018 $ 1,802,813   2,969,191 26,523 (1,152,197) (40,704)
Share-based compensation $ 97,258     97,258    
Shares issued for cash, Shares 132,893          
Shares issued for cash $ 5,379,860   5,379,860      
Shares issued for non-cash costs, Shares 8,468          
Shares issued for non-cash costs $ 118,759   118,759      
Comprehensive income (loss) $ (4,137,964)       (4,101,782) (37,182)
Ending Balance, Shares at Oct. 31, 2019 1,916,003 1,916,003        
Ending Balance at Oct. 31, 2019 $ 3,260,726   8,467,810 123,781 (5,252,979) (77,886)
Shares issued for cash, Shares   159,294        
Shares issued for cash 6,613,949   6,481,381      
Stock option expense 132,568     132,568    
Shares issued for non-cash costs 455,055     455,055    
Conversion of convertible debt, Shares   13,436        
Conversion of convertible debt 492,409   492,409      
Comprehensive income (loss) (5,119,336)       (4,842,463) (276,873)
Ending Balance, Shares at Jul. 31, 2020   2,088,733        
Ending Balance at Jul. 31, 2020 $ 5,702,803   15,441,600 711,404 (10,095,442) (354,759)
Beginning Balance, Shares at Oct. 31, 2019 1,916,003 1,916,003        
Beginning Balance at Oct. 31, 2019 $ 3,260,726   8,467,810 123,781 (5,252,979) (77,886)
Share-based compensation $ 245,847     245,847    
Shares issued for cash, Shares 159,294          
Shares issued for cash $ 6,481,381   6,481,381      
Conversion of convertible debt, Shares 13,436          
Conversion of convertible debt $ 492,409   492,409      
Share-based professional fees 455,055     455,055    
Comprehensive income (loss) $ (9,494,688)       (9,275,962) (218,726)
Ending Balance, Shares at Oct. 31, 2020 2,088,733 2,088,733        
Ending Balance at Oct. 31, 2020 $ 1,440,730   15,441,600 824,683 (14,528,941) (296,612)
Shares issued for cash, Shares   281,138        
Shares issued for cash 21,620,000   21,620,000      
Stock option expense 702,932     702,932    
Exercise of stock options $ 169,105   289,224 (120,119)    
Exercise of stock options, Shares 25,664 25,664        
Shares issued for non-cash costs, Shares   12,000        
Shares issued for non-cash costs     455,055 (455,055)    
Comprehensive income (loss) $ (21,590,783)       (21,590,783)  
Ending Balance, Shares at Jul. 31, 2021   2,407,535        
Ending Balance at Jul. 31, 2021 $ 2,341,984   $ 37,805,879 $ 952,441 $ (36,119,724) $ (296,612)